Birznieks Gunther, SVP of Business Development at Vanda Pharmaceuticals Inc. ($VNDA), made one open market sale of company shares in the last 365 days, totaling about $351 thousand. His most recent sale occurred on March 2, 2026. These sales rank 7,236th among 11,678 individual insiders, below the average sale amount of $8.6 million and 6.4 transactions per insider. Gunther had no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Vanda Pharmaceuticals Inc. | $VNDA | Birznieks Gunther | SVP, Business Development | S | Common Stock | 42431 | $8.27 | 494,197.0000 | 59,108,030 | 7.91% | 0.07% |
| Feb. 18, 2026 | Vanda Pharmaceuticals Inc. | $VNDA | Birznieks Gunther | SVP, Business Development | A | Common Stock | 125000 | $0.00 | 536,628.0000 | 59,108,030 | 30.37% | 0.21% |
| March 1, 2025 | Vanda Pharmaceuticals Inc. | $VNDA | Birznieks Gunther | SVP, Business Development | F | Common Stock | 26941 | $4.76 | 411,628.0000 | 58,316,044 | 6.14% | 0.05% |
| Feb. 18, 2025 | Vanda Pharmaceuticals Inc. | $VNDA | Birznieks Gunther | SVP, Business Development | A | Common Stock | 125000 | $0.00 | 438,569.0000 | 58,316,044 | 39.86% | 0.21% |
| March 5, 2024 | Vanda Pharmaceuticals Inc. | $VNDA | Birznieks Gunther | SVP, Business Development | S | Common Stock | 8684 | $4.13 | 313,569.0000 | 0 | 2.69% | 0.00% |
| March 4, 2024 | Vanda Pharmaceuticals Inc. | $VNDA | Birznieks Gunther | SVP, Business Development | S | Common Stock | 8727 | $4.30 | 322,253.0000 | 0 | 2.64% | 0.00% |
| Feb. 16, 2024 | Vanda Pharmaceuticals Inc. | $VNDA | Birznieks Gunther | SVP, Business Development | A | Common Stock | 125000 | $0.00 | 330,980.0000 | 0 | 60.69% | 0.00% |